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j ourna l homepage: www.e lsev ie r .com/ locate /atgGenomic advancement: Aiming to afﬁrm and improve human life☆Challenges to improving human health and well being are both
within and outside our control despite the best of scientiﬁc advances.
While advances continue to offer improved technologies, and thus our
ability to not only improve detection and treatment of disease,
preventing the roots of illness from taking hold involves environmental
and social factors. For example, climate and politics can aid or abet the
best of health improvement strategies yielding untoward consequences
for those in need who lack substantial control over their access to food
and healthcare.
In this issue, we present a collection of articles that contribute to our
understanding of genomics, ethical and policy factors necessary to im-
proving health. We start with a special section on the genomics of
plant breeding and move to translational genomics and health
improvement.
1. Special section: crop genomics and food security
Agriculture must overcome some daunting challenges if it is to meet
the demands of an increasing world population and rising per capita
consumption in the coming decades, including climate change, insufﬁ-
cient fresh water, soil erosion, salination, and pollution, as well as the
use of crop commodities for fuel as well as food, the advent of peak
oil, and competition for land use. If it is to meet the demand for food
in the face of these challenges, plant breeding will have to bring about
increases in crop yield at a much faster rate than it is currently achiev-
ing, while improving, or at least maintaining, food quality and safety.
Genomics and systems biology, along with biotechnology, will be key
to making this possible.
This special section on agricultural genomics comprises three papers
on wheat. Although wheat production has been overtaken by that of
maize and rice in recent years, wheat grain remains the most traded
crop commodity on world markets, the leading crop source of protein
and, along with rice, one of the two most important crop products for
human consumption. However, wheat yield has leveled off in many re-
gions of theworld in the last two to three decades; a trend that must be
reversed as demand increases.
In the ﬁrst paper, Carlos Guzman and colleagues review the use of
genomic selection in the Global Wheat Program of the International
Center for Maize and Wheat Improvement (CIMMYT) in Mexico. This
program aims to increase the productivity of wheat cropping systems
in developing countries, but its priorities of high grain yield, disease re-
sistance, tolerance to abiotic stresses (drought and heat), and end-use
quality are familiar to wheat breeders everywhere. Genomic selection☆ A priori argument alone is not enough. One must square the most likely explanation
with the observed facts. Aristotle
http://dx.doi.org/10.1016/j.atg.2016.11.002
2212-0661/© 2016 The Authors. Published by Elsevier B.V. This is an open access article underusing genome-wide single nucleotide polymorphism markers is being
applied to multiple quantitative traits in a breeding pipeline involving
thousands of lines.
Olufunmilayo Ladejobi and colleagues, led by Alison Bentley at the
National Institute of Agricultural Botany (NIAB) in Cambridge, UK, re-
view the use of multi-parent populations in quantitative trait mapping
and elucidating the genetic basis of complex crop traits.
Lastly, Keywan Hassani-Pak of Rothamsted Research in the UK and
colleagues describe bio-mathematical approaches to investigating the
genetic basis of crop traits, incorporating gene discovery and the con-
struction of networks of genetic interactions. These approaches, which
the team applies to wheat and its close relative, barley, will enable re-
searchers to mine the huge amount of genetic information that is al-
ready available but is dispersed in databases that use a variety of
formats and have variable quality and coverage.
Together, these three reviews, describe quite different technologies
and illustrate the potential that genomics has for accelerating crop ge-
netic research and its application in crop breeding programs.2. Special section: social considerations in translational genomics
The path to ensuring sound and ethical application of translational
genomics requires arguably greater scholarly attention to social factors.
In this last section, we present articles that advance our knowledge of
these factors and their relevance to achieving the desired beneﬁt of ge-
nomic applications.
The ﬁrst paper by Rahimzadeh, et al. addresses the as yet unknown
path from cell-based therapies and products (CTP) manufacturing to
translation to clinical adoption. Filling an empirical gap in the literature,
this study elucidates Canadian institutional practices and stakeholder
perceptions in efforts to advance knowledge about how best to ensure
appropriate and ethical commercialization and regulation.
Reznichenko, et al. discuss technical and ethical challenges in the
clinical use of mitochondrial transfer to prevent mitochondrial disease;
success rates of various techniques, counter arguments against potential
mitochondrial-nuclear genome incompatibility and various clinical
applications.
Lastly, Aarden, et al. address the need for scholarly attention to social
infrastructures into which genomic interventions may be delivered to
patient populations. The paper explores how the assessment of familial
breast cancer risks was ‘translated’ into routine health care in Germany,
the Netherlands and the UK, evincing why translation to the clinic is an
area of social, aswell as technical, concern requiring collective decision-
making.
Finally, with regret, the ﬁnal issue of 2016 is the ﬁnal issue of ATG/
Elsevier. It has been my personal honor to work with such an esteemedthe CC BY license (http://creativecommons.org/licenses/by/4.0/).
2 Genomic advancement: Aiming to afﬁrm and improve human lifeeditorial board andmy hope that wewill continue our work together in
a different context. I hope that you, our readers, have beneﬁted and
enjoyed our issues over the past three years.
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